MEDVIA announces US internationalization program for 2024: workshop series + US mission
25 January 2024
Updated: 07 February 2024
MEDVIA is pleased to announce our new internationalization program for 2024. “Say yes to the US” is a seven-part series on breaking into the US market, organized in partnership with Smart Hub Flemish Brabant and MEDVIA member Crowell & Moring.
The program kicked-off on 25 January in Leuven and will culminate with a mission to one of America’s healthtech hubs in the second half of October, taking in events and visits to clusters and accelerators.
Why a program on the US?
The regulatory environment in Europe for healthtech innovations can be complicated and time-consuming, while the US is home to a large single market. This means that some start-ups should consider launching their product in the US first. Other companies will be looking to expand their market beyond Europe.
For some innovations, faster impact can be achieved in the US, and can also be more lucrative. Reimbursement policies are streamlined, making building a business case easier and faster. If you want to get your company going and raise the capital to launch in your home market, the US can be an excellent place to start.
Even for R&D companies without products to put on the market, keeping an eye on the US is important. Non-dilutive R&D funds for starters and scale-ups through government grants and funding is definitely worthwhile to follow! Every session will feature special guests who are experts in the topic.
When and where are the sessions?
The sessions will take place monthly, from January to June, in either Brussels or Flemish Brabant. The final gathering, early in September, will be a preparatory session for a mission MEDVIA organizes to the US. The date for this session will be communicated soon.
The mission to the US will take place over one week in October. We are planning to select a trade show or conference that brings the most value to our members.
In the meantime, you can register for sessions 2 and 3! If you missed the introductory session, you can still take part in the program. You can register for any session you choose.
Say Yes to the US
Session 2: Entry strategies and considerations
29 February, 14.00-17.30
Crowell & Moring, 7 Rue Joseph Stevens, Brussels
The program for session 2 includes:
- Market Entry Strategies by Lex Eley, Partner at Crowell & Moring, Washington, DC
- Case studies panel: When and how to enter the US market
Panelists: Peter Kinhan, CEO of Dermicus / Lex Eley, Partner at Crowell & Moring / Ward Servaes, co-founder of moveUP
- Networking drink
Future session dates and topics:
Session 3: Choosing a landing site / Meet MEDVIA’s partner hubs
27 March, 11.30-14.00
BNP Paribas Fortis, 1 Rue de la Chancellerie, Brussels
(Part of larger event Build Your Bridges with the United States)
Special registration form here
Session 4: FDA Regulations / Tips & tricks for navigating and collaborating with the FDA
Session 5: Important regulatory & strategic considerations / Geopolitical situation, reimbursement, US healthcare system
Session 6: Forward thinking / How the US views emerging technologies, US-specific opportunities
Session 7: Preparing for mission to the US
Who can attend the internationalization series?
Say yes to the US, which includes the seven-part series and the mission to the US, is open to all healthtech companies wanting to learn more about doing business in the US. Companies should be involved in R&D activities. It is possible to attend all or part of the sessions, whether or not you attend the mission in the autumn. It is also possible to join the mission without participating in the sessions. Though if plan to join us for the mission, we highly recommend joining us for the sessions!
How much does it cost?
MEDVIA members: Free
Companies based in Flemish Brabant: Free
Members of BioWin or Lifetech.Brussels: €175 per person per session
Others: €250 per person per session
Exception: Session 3 takes place as part of an event hosted by the American Embassy in Belgium. Therefore, there is no charge for anyone to attend this session
Sessions are free for MEDVIA members and for companies based in Flemish Brabant. This is due to a partnership with Smart Hub Flemish Brabant. A no-show fee of €250 will apply to organizations attending for free. There is an exception for Session 3 (see above).
Anyone planning to take part in the mission is advised to set aside some €5,000 for travel, accommodation and event fees. We will communicate later about any subsidies or discounts that might be available.
Session 1: Why go to the US?
25 January, 14.00-17.00
De Hoorn, Sluisstraat 79, Leuven
Program, session 1:
- Welcome & check-in
- Introduction to the series
- Doing business in the US and working with Americans: Real-world experiences and insights
- Case studies panel: Why didy ou launch in the US? Featuring: Jan Verheyden, VP Partnerships at Icometrix / Kathleen Verleysen, CEO of miDiagnostics / Julien Penders, COO of Bloomlife
MEDVIA’s greater strategy
Say yes to the US is part of MEDVIA’s Tackling Global Markets strategy. This strategy is one of several we will be rolling out in 2024. What are the others? We’re glad you asked:
- Tackling the Home Market (BE/EU)
- The Future of Healthcare (Futureproofing the Belgian healthtech sector)
- Money, Money, Money (Getting funding, including our project calls)
MEDVIA will position our programming in 2024 within these strategies.
Say yes to the US is held in partnership with: